Recon: FDA staff indicate support for full approval of Eisai Alzheimer’s drug; EU approves GSK’s RSV vaccine Arexvy
ReconJoanne S. EglovitchBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy